We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
(-43%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-89.66%
Top 10 Holdings %
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1
quarters
Top 10 Avg Time Held Equity + Options
0.1
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
4.3
quarters
Top 10 Avg Time Held Equity only
0.1
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pioneer Natural Resource Co.
PXD
|
+$604M |
| 2 |
Splunk Inc
SPLK
|
+$446M |
| 3 |
Hess
HES
|
+$339M |
| 4 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$106M |
| 5 |
US Steel
X
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.06B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$887M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$371M |
| 4 |
VMW
VMware, Inc
VMW
|
+$354M |
| 5 |
NEWR
New Relic, Inc.
NEWR
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 29.51% |
| 2 | Technology | 21.97% |
| 3 | Healthcare | 10.49% |
| 4 | Miscellaneous | 10.26% |
| 5 | Real Estate | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
476
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
| $1.77K | ﹤0.01% |
130,406
| – | – |
2021 Q4
8 quarters
|
|
477
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
| $1.76K | ﹤0.01% |
231,101
| – | – |
2022 Q1
7 quarters
|
|
478
PUT
Hyatt Hotels
H
$15.2B
| $1.5K | ﹤0.01% |
12,000
-90,000
| -88% | -$10.2M |
2022 Q1
7 quarters
|
|
479
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
| $1.42K | ﹤0.01% |
283,281
| – | – |
2021 Q2
10 quarters
|
|
480
CALL
Ultragenyx Pharmaceutical
RARE
$1.5B
| $1.25K | ﹤0.01% |
10,000
-85,000
| -89% | -$3.3M |
2023 Q2
2 quarters
|
|
|
FICVW
481
DELISTED
Frontier Investment Corp Warrants
FICVW
| $1.17K | ﹤0.01% |
32,524
| – | – |
2021 Q3
9 quarters
|
|
482
Alliance Entertainment Holding Corp Warrants
AENTW
$1.53M
| $993 | ﹤0.01% |
116,781
| – | – |
2023 Q2
2 quarters
|
|
483
PUT
Hilton Worldwide
HLT
$73.8B
| $700 | ﹤0.01% |
14,000
| – | – |
2022 Q1
7 quarters
|
|
484
PUT
OneMain Financial
OMF
$6.44B
| $502 | ﹤0.01% |
20,100
| – | – |
2022 Q3
5 quarters
|
|
485
PUT
Expedia Group
EXPE
$32.4B
| $440 | ﹤0.01% |
11,000
| – | – |
2022 Q2
6 quarters
|
|
486
PUT
DraftKings
DKNG
$9.72B
| $412 | ﹤0.01% |
82,500
| – | – |
2022 Q1
7 quarters
|
|
487
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
| $208 | ﹤0.01% |
18,392
| – | – |
2023 Q1
3 quarters
|
|
488
American Airlines Group
AAL
$8.33B
| – | – |
-50,000
| Closed | -$628K | – |
|
489
Acumen Pharmaceuticals
ABOS
$146M
| – | – |
-69,538
| Closed | -$289K | – |
|
490
CALL
Aclaris Therapeutics
ACRS
$534M
| – | – |
-70,000
| Closed | -$117K | – |
|
|
491
Aclaris Therapeutics
ACRS
$534M
| – | – |
-68,014
| Closed | -$466K | – |
|
492
Agnico Eagle Mines
AEM
$95.3B
| – | – |
-100,000
| Closed | -$4.54M | – |
|
493
AES
AES
$10.7B
| – | – |
-422,400
| Closed | -$6.42M | – |
|
494
Align Technology
ALGN
$10B
| – | – |
-5,300
| Closed | -$1.62M | – |
|
495
PUT
Ally Financial
ALLY
$11.6B
| – | – |
-175,000
| Closed | -$228K | – |
|
496
CALL
Alnylam Pharmaceuticals
ALNY
$30.4B
| – | – |
-14,000
| Closed | -$21.3K | – |
|
|
497
PUT
Alnylam Pharmaceuticals
ALNY
$30.4B
| – | – |
-10,000
| Closed | -$14.3K | – |
|
498
Amylyx Pharmaceuticals
AMLX
$3.46B
| – | – |
-35,000
| Closed | -$641K | – |
|
499
CALL
American Superconductor
AMSC
$1.44B
| – | – |
-30,500
| Closed | -$11.4K | – |
|
500
CALL
Annexon
ANNX
$755M
| – | – |
-300,000
| Closed | -$30K | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2023 Portfolio in Review
As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.
By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.
- UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
- UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
- UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
- UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
- UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
- UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.
Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.